基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by Kent Mark D.. Director active across 2 companies, notably Cano Health, Inc.. Cumulatively, 4 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €170k. Activity tracked since 2 June 2026. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Kent Mark D. is a declarant linked to Alignment Healthcare, Inc. and Cano Health, Inc., where he is listed as President - MSO and Interim CEO. He has 4 filings in total, and across the sampled recent filings the total buy amount is EUR 170157, with no sells, between 2023-07-14 and 2026-06-09.